助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   benign ovarian tumor 的翻译结果: 查询用时:0.218秒
图标索引 在分类学科中查询
所有学科
妇产科学
肿瘤学
更多类别查询

图标索引 历史查询
 

benign ovarian tumor
相关语句
  良性卵巢肿瘤
     FLT 1, FLK 1 mRNA were expressed in 27 of 70(38.6%) and 18 of 70(25.7%)epithelial ovarian cancer tissues respectively, but not in benign ovarian tumor tissues.
     FLT1mRNA、FLK1mRNA在部分卵巢上皮性癌组织中表达,分别为38.6%(27/70)和25.7%(18/70),而在良性卵巢肿瘤组织中未见表达。
短句来源
     VEGF121 mRNA expression was stronger than VEGF165 mRNA expression(P=0.000)in epithelial ovarian cancer tissues, whereas there was no significant difference in benign ovarian tumor tissues (P=0.667).
     在卵巢上皮性癌组织中,VEGF121mRNA表达高于VEGF165mRNA(P=0.000),而在良性卵巢肿瘤组织中两者表达水平差异无显著性(P=0.667)。
短句来源
     RESULTS:①The positive rate of UPA in ovarian cancer,benign ovarian tumor and normal ovary tissues was 53.3%,10%and 5%respectively,among which there were significant differences(P< 0.05).
     结果:①UPA在卵巢腺癌、良性卵巢肿瘤、正常卵巢组织中的阳性表达分别为53%,10%,5%,阳性表达率间差异均存在显著性意义(P<0.05)。
短句来源
     Serum β_2 - microglobulin ( β_2 - M ) was determined by radioimmunoassay in 201 wo -men, including 42 with ovarian carcinoma, 72 with benign ovarian tumor and 87 normal controls .
     用放射免疫分析法对201例女性血清β_2微球蛋白(β_2-M)进行检测,其中卵巢癌组42例,良性卵巢肿瘤组72例和正常对照组87例.
短句来源
     The IS value was 9.09±1.83%,9.63±1.52% respectively for patients with benign ovarian tumor and the health women.
     良性卵巢肿瘤及健康妇女的IS均值分别为 9.0 9± 1.83%、9.6 3± 1.5 2 %。
短句来源
更多       
  卵巢良性肿瘤
     Methods: The immune function of erythrocyte and T-lymphocyte subpopulation in 47 patients with benign ovarian tumor were studied, that the rate of RBC-C3b receptor rosette (RBC-C3bRR), RBC immunocomplex rosette (RBC-ICR), tumor-RBC rosette (RBC-TRR) and CD3, CD4, CD8 cells as observation index.
     方法:以红细胞C3b受体花环率(RBC-C3bRR)、红细胞免疫复合物花环率(RBC-ICR)、肿瘤红细胞花环率(RBC-TRR)及CD3、CD4、CD8细胞作为观测指标,测定47例卵巢良性肿瘤及瘤样病变患者术前、术后第1天和第3天免疫指标的变化。
短句来源
     Results The expression of Ki67 in ovarian cancer was more higher than that in benign ovarian tumor (P<0.01);
     结果 Ki67在卵巢癌组织中的表达显著高于卵巢良性肿瘤(P<0.01);
短句来源
     Results The plasma LPA levels is 6.10±2.62μmol L in ovarian cancer group while 2.35±1.57μmol L in benign ovarian tumor group. There is a significant difference in two groups P<0.01.
     结果卵巢癌患者血浆LPA水平(6.10±2.62)μmolL,卵巢良性肿瘤患者血浆LPA水平(2.35±1.57)μmolL,两组比较差异有显著性意义(t=7.35,P<0.01)。
短句来源
     The P16 and P27 expressions in ovarian epithelial carcinoma were obviously lower than those in benign ovarian tumor and in normal tissues.
     P27蛋白在卵巢上皮性恶、良性肿瘤和正常组织中阳性表达率分别为32%,65%和78%,P16和P27蛋白在卵巢上皮性恶性肿瘤中的表达明显低于卵巢正常组织和卵巢良性肿瘤.
短句来源
     Methods Serum levels of CA125 and CA72-4 in 58 patients with ovarian carcinoma, 48 patients with benign ovarian tumor and 50 normal controls were measured by Elctrochemiluminescence immuno-assay (ECLIA).
     方法卵巢癌患者58例、卵巢良性肿瘤患者48例及健康妇女50例的血清样品,用电化学发光免疫测定法测定CA125和CA72—4含量。
短句来源
更多       
  例卵巢良性肿瘤
     Methods: The immune function of erythrocyte and T-lymphocyte subpopulation in 47 patients with benign ovarian tumor were studied, that the rate of RBC-C3b receptor rosette (RBC-C3bRR), RBC immunocomplex rosette (RBC-ICR), tumor-RBC rosette (RBC-TRR) and CD3, CD4, CD8 cells as observation index.
     方法:以红细胞C3b受体花环率(RBC-C3bRR)、红细胞免疫复合物花环率(RBC-ICR)、肿瘤红细胞花环率(RBC-TRR)及CD3、CD4、CD8细胞作为观测指标,测定47例卵巢良性肿瘤及瘤样病变患者术前、术后第1天和第3天免疫指标的变化。
短句来源
     Method:The expressions of VEGF and its receptor FLT 1, FLK 1 mRNA were analized by reverse transcription polymerase chain reaction(RT PCR) in the specimens from 70 patients with epithelial ovarian cancer and 22 patients with benign ovarian tumor.
     方法采用逆转录聚合酶链反应技术检测70例卵巢上皮性癌及22例卵巢良性肿瘤病变组织标本中VEGFmRNA及其受体FLT1mRNA及FLK1mRNA的表达。
短句来源
     Methods Immunohistochemistrical SP method was used to detect the expression of EGFR in 15 cases of normal ovarian tissue and 15 cases of benign ovarian tumor and 60 cases ovarian cancer.
     方法应用免疫组织化学法(SP方法),检测15例正常卵巢组织,15例卵巢良性肿瘤组织及60例卵巢癌组织中EGFR的表达情况。
短句来源
     The CA 125 value was above 35 U/ml in 31% (5/16) in patients with benign ovarian tumor and only 14% (2/14) in healthy female.
     16例卵巢良性肿瘤中,以≤35U/ml为正常值,阳性率为31%(5/16),若以≤65U/ml为正常值,阳性率为6%(1/16);
短句来源
     Methods Immunohistochemical staining was conducted to detect PTEN and mtP53 Gene expression in 31 cases of benign ovarian tumor and 32 cases of normal ovarian tissue as well as 74 cases of epithelial ovarian cancer.
     方法利用免疫组织化学技术分别检测32例正常卵巢者及31例卵巢良性肿瘤、74例上皮性卵巢癌患者PTEN、m tP53表达情况。
短句来源
更多       
  “benign ovarian tumor”译为未确定词的双语例句
     The positive rates of P27 in normal ovarian group, benign ovarian tumor group and in epithelial ovarian carcinoma group were 90.00%,80.00% and 36.67% respectively, strong positive rates were 30.00%, 20.00% and 6.67%.
     P27基因蛋白在正常卵巢组、良性上皮性卵巢肿瘤组及上皮性卵巢癌组的阳性率分别为90.00%、30.00%、36.67%,强阳性率分别为30.00%,20.00%,6.67%。
短句来源
     Results: (1) The positive rates of P21 were increasingly decrease in normal ovarian group, benign ovarian tumor group and in epithelial ovarian carcinoma group,which were 100.00%, 90.00% and 63.33% respectively; strong positive rates were 40.00%, 20.00% and 16.67%.
     结果:(1)在正常卵巢组、良性上皮性卵巢肿瘤组及上皮性卵巢癌组,P21基因蛋白总阳性表达率逐渐下降,分别是100.00%,90.00%,63.33%,强阳性率分别为40.00%、20.00%、16.67%。
短句来源
     Results The serum levels of VEGF were increased in turn in benign ovarian tumor,borderline ovarian tumor and ovarian carcinoma,which were(686±150)ng/L,(750±90)ng/L and(1183±293)ng/L respectively(P<0.01);
     结果良性、交界性及恶性卵巢上皮肿瘤患者血VEGF水平依次升高分别为(686±150)、(750±90)和(1183±293)ng/L,P<0.01;
短句来源
     Results ①The positive rate of MUC5AC in benign ovarian tumor,borderline ovarian tumor,ovarian cancer were 55%,50% and 22%,respactively(P=(0.0044));
     结果①原发性良性、交界性、恶性卵巢肿瘤MUC5AC的阳性表达依次为55%(11/20)、50%(10/20)、22%(11/50),P=0.0044;
短句来源
     Results The positive rates of P21 and P27 in normal ovarian and benign ovarian tumor groups were higher than that in ovarian carcinoma (P=0.014,0.004).
     结果正常卵巢组织、良性肿瘤组织P21、P27蛋白阳性表达率与卵巢癌组织比较,差异有显著性(P=0.014、0.004)。
短句来源
更多       
查询“benign ovarian tumor”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  benign ovarian tumor
Therefore, we suggest that CA 125 is useful for differentiation between benign ovarian tumor and ovarian cancer.
      
On the other hand, only one patient with benign ovarian tumor had a positive CA 125 value.
      
Comparison was made between lymphocyte subsets in peripheral blood from patients with benign ovarian tumor and those with advanced ovarian carcinoma.
      
In the present case, a preoperative diagnosis of benign ovarian tumor could not be made due to the elevation of CA125 (895 U/ml) and nonspecific MRI findings.
      
The mechanism for the unusual uptake of 131I in a benign ovarian tumor is not clear, and the differential diagnosis of metastatic thyroid cancer is briefly reviewed.
      
更多          


Factor Ⅷ related antigen (ⅧR:Ag), fibrin (fibrinogcn) degradation products (FDP), lactic dchydrogcnase (LDH) and erythrocyte sedimentation rate (ESR) were determined in 119 female patients suffering from pelvic tumors. The mean level of ⅧR:Ag in 39 cases of malignant ovarian tumors was 192.98%, compared with the mean level, 103.92%, in 31 normal women as control group, showing a significant difference (P<0.001). However, the mean levels in 23 cases of benign ovarian tumor and in 32 cases of hysteromyoma...

Factor Ⅷ related antigen (ⅧR:Ag), fibrin (fibrinogcn) degradation products (FDP), lactic dchydrogcnase (LDH) and erythrocyte sedimentation rate (ESR) were determined in 119 female patients suffering from pelvic tumors. The mean level of ⅧR:Ag in 39 cases of malignant ovarian tumors was 192.98%, compared with the mean level, 103.92%, in 31 normal women as control group, showing a significant difference (P<0.001). However, the mean levels in 23 cases of benign ovarian tumor and in 32 cases of hysteromyoma were 98.47% and 117.63% respectively, giving no significant difference as compared with the normal women(P>0.05). The determination of ⅧR:Ag is therefore of some value in the diagnosis of malignant ovarian tumor. In addition, the determination of FDP, LDH and ESR also seemed to be helpful in the differential diagnosis of malignant and benign tumors. It is suggested that further examination or laparotomy is needed for early diagnosis of pelvic tumors in women if more than two abnormal parameters mentioned above are present.

本文对119例盆腔肿块及其它妇科癌症患者进行下列四项化验测定:因子Ⅷ相关抗原(因子ⅧR∶Ag)、纤维蛋白降解产物(FDP)、乳酸脱氢酶(LDH)、血沉(ESR)。因子ⅧR∶Ag测定结果,恶性卵巢肿瘤39例的测定均值为192.98%,与正常妇女31名对照组的均值105.92%相比,P值<0.001,有显著差异;良性卵巢肿瘤23例的均值98.47%,子宫肌瘤32例的均值117.63%,与对照组相比,P值均>0.05,无显著差异.因子ⅧR∶Ag对诊断恶性卵巢肿瘤是有价值的。FDP、LDH、ESR测定结果对诊断恶性卵巢肿瘤也有一定价值。因此凡有盆腔肿块的患者,如有上述两项以上化验结果异常者,则应进一步检查甚至剖腹探查,将有助于卵巢恶性肿瘤的早期诊断。

3 cloned hybridoma cell lines were obtained by fusion of murine myeloma cells with spleen lymphocytes from BALB/c mice immunized with soluble antigen prepared from two ovarian serous papillary adenocarcinoma. One of the 3 cell lines proved to be antibody-producing after storage over 4 months was named MAb COC 166-9. Chromosome count was 95 and the subclass was identified to be IgG_1. No cross reactions with A or B red cell grouping substances, HLA, CEA, nor αFP were observed. The selected COC 166-9 clone was...

3 cloned hybridoma cell lines were obtained by fusion of murine myeloma cells with spleen lymphocytes from BALB/c mice immunized with soluble antigen prepared from two ovarian serous papillary adenocarcinoma. One of the 3 cell lines proved to be antibody-producing after storage over 4 months was named MAb COC 166-9. Chromosome count was 95 and the subclass was identified to be IgG_1. No cross reactions with A or B red cell grouping substances, HLA, CEA, nor αFP were observed. The selected COC 166-9 clone was positively stained against 8 ovarian epithelial carcinomas by indirect immunofluorescence. Careinoma of lung and breast, benign ovarian tumor, myeloma of uterus as well as normal ovary were all negatively stained except one case of carcinoma of rectum. Thus the use of COC 166-9 may have a bright future in the diagnosis of ovarian epithelial carcinomas.

用卵巢浆液性乳头状囊腺癌可溶性抗原免疫小鼠,制备单克隆抗体。经连续培养,低温冻存4个月后复甦,其中一株仍能分泌抗体,称为COC 166-9。染色体计数为95,为lgG_1亚型,证明不是人类血型物质;与HLA、CEA和αFP均无交叉。间接免疫荧光染色与8例卵巢上皮癌阳性;与肺癌、乳癌、良性卵巢肿瘤和正常卵巢等均阴性。实验证明单克隆抗体COC 166-9很有前途。

The result of radioimmunoassay (RIA) for cancer antigen 125 (CA 125) in 36 cases of benign and malignant ovarian tumors was reported. The CA 125 level was elevated (>35U/ml) in 80% (12/15) in patients with epithelial ovarian carcinoma and in 75% (15/20) in all (20 cases) of malignant ovarian tumors. The CA 125 value was above 35 U/ml in 31% (5/16) in patients with benign ovarian tumor and only 14% (2/14) in healthy female. The results showed that the CA 125 value was rather high in ovarian carcinoma,...

The result of radioimmunoassay (RIA) for cancer antigen 125 (CA 125) in 36 cases of benign and malignant ovarian tumors was reported. The CA 125 level was elevated (>35U/ml) in 80% (12/15) in patients with epithelial ovarian carcinoma and in 75% (15/20) in all (20 cases) of malignant ovarian tumors. The CA 125 value was above 35 U/ml in 31% (5/16) in patients with benign ovarian tumor and only 14% (2/14) in healthy female. The results showed that the CA 125 value was rather high in ovarian carcinoma, while the false-positive rate was low in normal female. It is suggested that the RIA of CA 125 was a useful assay in the diagnosis of ovarian carcinoma.

本文报告癌抗原(CA125)放射免疫测定50例卵巢良、恶性肿瘤患者和正常女性血清反应的临床价值:20例卵巢恶性肿瘤中,以≤35U/ml为正常值,阳性率为75%(15/20);若以≤65U/ml为正常值,阳性率为60%(12/20)。16例卵巢良性肿瘤中,以≤35U/ml为正常值,阳性率为31%(5/16),若以≤65U/ml为正常值,阳性率为6%(1/16);14例正常女性中CA125值>35U/ml的阳性率为14%(2/14),但无1例>65U/ml。结果表明,CA125放射免疫测定在诊断卵巢恶性肿瘤中有一定意义。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关benign ovarian tumor的内容
在知识搜索中查有关benign ovarian tumor的内容
在数字搜索中查有关benign ovarian tumor的内容
在概念知识元中查有关benign ovarian tumor的内容
在学术趋势中查有关benign ovarian tumor的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社